[PDF][PDF] Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor

…, T Yamaguchi, T Nomura, M Ono, Z Amoura… - Immunity, 2009 - cell.com
FoxP3 is a key transcription factor for the development and function of natural CD4 + regulatory
T cells (Treg cells). Here we show that human FoxP3 + CD4 + T cells were composed of …

IgA dominates the early neutralizing antibody response to SARS-CoV-2

…, K Dorgham, P Charneau, Z Amoura… - Science translational …, 2021 - science.org
Humoral immune responses are typically characterized by primary IgM antibody responses
followed by secondary antibody responses associated with immune memory and composed …

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

S Rust, M Rosier, H Funke, J Real, Z Amoura… - Nature …, 1999 - nature.com
Tangier disease (TD) was first discovered nearly 40 years ago in two siblings living on Tangier
Island 1. This autosomal co-dominant condition is characterized in the homozygous state …

[HTML][HTML] Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) …

GK Bertsias, M Tektonidou, Z Amoura… - Annals of the …, 2012 - ard.bmj.com
Objectives To develop recommendations for the management of adult and paediatric lupus
nephritis (LN). Methods The available evidence was systematically reviewed using the …

The 2023 ACR/EULAR antiphospholipid syndrome classification criteria

…, F Manneville, MC Amigo, Z Amoura… - Arthritis & …, 2023 - Wiley Online Library
Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …

EULAR recommendations for the management of antiphospholipid syndrome in adults

…, L Andreoli, M Limper, Z Amoura… - Annals of the …, 2019 - ard.bmj.com
The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E …

…, S Besnard, J Donadieu, Z Amoura - Blood, The Journal …, 2013 - ashpublications.org
Histiocytoses are rare disorders of unknown origin with highly heterogeneous prognosis.
BRAF V600E gain-of-function mutations have been observed in 57% of cases of Langerhans …

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

…, A Fernández-Nebro, M Haro, Z Amoura… - Annals of the …, 2015 - ard.bmj.com
Objectives To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid
syndrome (APS) during a 10-year-follow-up period and to compare the frequency of …

Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal …

Z Amoura, S Koutouzov, H Chabre… - … : Official Journal of …, 2000 - Wiley Online Library
Amoura and Koutouzov contributed equally to this work. Address reprint requests to Zahir
Amoura, MD, Service de Médecine Interne, Groupe Hospitalier Pitié-Salpêtrie`re, 47-83 Boule…

Global natural regulatory T cell depletion in active systemic lupus erythematosus

M Miyara, Z Amoura, C Parizot, C Badoual… - The Journal of …, 2005 - journals.aai.org
The immune defect that could account for the multisystemic involvement that characterizes
systemic lupus erythematosus (SLE) remains unknown. We hypothesized that iterative …